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Background
Oligoarticular JIA is presently unpredictable in its course
and can become more severe after an initially mild onset.
We examined the cellular and molecular composition of
the first synovial fluid (SF) aspirates from oligoarticular
JIA patients to discover markers that predict an increase in
number of joints involved and thus, extension to more
severe phenotype (extended oligoarticular JIA).
Methods
Flow cytometry was used to quantify T cells subsets, NK
cells, B cells, dendritic cells, macrophages and other
CD13+ cells in 33 (22 who had persistent outcome, 11
who later extended) synovial fluid mononuclear cell
(SFMC) samples. From 22 of these (14 persistent, 8 who
later extended) SFMC RNA were hybridized to Affymetrix
U133v2 gene expression microarrays.
Results
Logistic regression produced a model that predicted exten-
sion correctly in 91% of the study group using CD8+ T
cell, CD4+ T cell and CD19+ B cell proportions of the total
live cells from each patient's SFMC. 62 genes were found
to be 1.5-fold differently expressed between the two phe-
notypic groups with a significance of p < 0.01. A group of
genes expressed in activated macrophages were among
those more highly expressed in the extended outcome
phenotype.
Conclusion
Our data suggest that in children with early oligoarthritis,
deterioration of disease can be predicted by cell composi-
tion or gene expression from synovial fluid cells. If these
findings are replicated in a new set of samples, they may
represent a major step forward in our understanding of
mechanisms governing severity in childhood arthritis.
from 15th Paediatric Rheumatology European Society (PreS) Congress
London, UK. 14–17 September 2008
Published: 15 September 2008
Pediatric Rheumatology 2008, 6(Suppl 1):S31 doi:10.1186/1546-0096-6-S1-S31
<supplement> <title> <p>15<sup>th </sup>Paediatric Rheumatology European Society (PreS) Congress</p> </title> <editor>Wietse Kuis, Patricia Woo, Angelo Ravelli, Hermann Girschick, Michaël Hofer, Johannes Roth, Rotraud K Saurenmann, Alberto Martini, Pavla Dolezova, Janjaap van der Net, Pierre Quartier, Lucy Wedderburn and Jan Scott</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/PDF/1546-0096-6-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.ped-rheum.com/content/6/S1/S31
© 2008 Hunter et al; licensee BioMed Central Ltd. 